Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,444,122
-
Total 13F shares
-
44,941,406
-
Share change
-
+177,235
-
Total reported value
-
$519,510,607
-
Price per share
-
$11.56
-
Number of holders
-
269
-
Value change
-
-$420,421
-
Number of buys
-
129
-
Number of sells
-
119
Institutional Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q3 2025
As of 30 Sep 2025,
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,941,406 shares.
The largest 10 holders included
BlackRock, Inc., T. Rowe Price Investment Management, Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, BROWN ADVISORY INC, STATE STREET CORP, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, and AQR CAPITAL MANAGEMENT LLC.
This page lists
270
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.